Total Payments
$3,726
2024 Payments
$1,037
Companies
21
Transactions
33
Medicare Patients
796
Medicare Billing
$72,002
Payment Breakdown by Category
Food & Beverage$3,726 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,726 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $438.70 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $360.01 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $249.94 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $234.43 | 2 | $0 (2023) |
| ABBVIE INC. | $229.37 | 3 | $0 (2023) |
| Gilead Sciences, Inc. | $224.99 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $200.85 | 2 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $197.82 | 2 | $0 (2024) |
| Hologic Sales and Service, LLC | $132.84 | 1 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $124.99 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,037 | 9 | Hologic Sales and Service, LLC ($132.84) |
| 2023 | $1,056 | 9 | AstraZeneca Pharmaceuticals LP ($245.80) |
| 2022 | $833.06 | 7 | Bayer HealthCare Pharmaceuticals Inc. ($125.05) |
| 2021 | $800.16 | 8 | Genentech USA, Inc. ($438.70) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $72.77 | General |
| Category: Cardio-renal | ||||||
| 12/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $119.83 | General |
| Category: Gastroenterology | ||||||
| 08/09/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $132.84 | General |
| Category: Diagnostics | ||||||
| 07/25/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $111.70 | General |
| Category: Oncology | ||||||
| 06/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $111.15 | General |
| Category: Central Nervous System | ||||||
| 03/21/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Pulmonology | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 11/08/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2023 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $120.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $112.69 | General |
| Category: Oncology | ||||||
| 08/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $89.70 | General |
| Category: Central Nervous System | ||||||
| 07/19/2023 | ABBVIE INC. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $107.54 | General |
| Category: WOMENS HEALTH | ||||||
| 06/26/2023 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/15/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2023 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: HIV | ||||||
| 12/14/2022 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $114.51 | General |
| Category: INSOMNIA | ||||||
| 09/14/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: Diabetes Care | ||||||
| 09/07/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $124.95 | General |
| Category: Neuropsychiatry | ||||||
| 07/19/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $121.74 | General |
| Category: Oncology | ||||||
| 07/14/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 06/08/2022 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: HIV | ||||||
| 02/01/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.05 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 458 | 812 | $108,343 | $41,539 |
| 2022 | 8 | 204 | 302 | $81,717 | $18,424 |
| 2021 | 3 | 55 | 59 | $50,811 | $4,990 |
| 2020 | 3 | 79 | 82 | $70,829 | $7,049 |
Total Patients
796
Total Services
1,255
Medicare Billing
$72,002
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 114 | 300 | $34,455 | $13,889 | 40.3% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 45 | 116 | $13,920 | $5,047 | 36.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 47 | 69 | $10,350 | $4,410 | 42.6% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2023 | 37 | 43 | $5,375 | $3,667 | 68.2% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 29 | 29 | $5,075 | $2,886 | 56.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 28 | $10,792 | $2,168 | 20.1% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 27 | 35 | $6,300 | $2,125 | 33.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 29 | 43 | $4,945 | $2,026 | 41.0% |
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 12 | 16 | $4,000 | $1,814 | 45.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 17 | 19 | $2,850 | $1,316 | 46.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 53 | 67 | $5,025 | $1,312 | 26.1% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 16 | 34 | $4,216 | $673.88 | 16.0% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 11 | 13 | $1,040 | $204.12 | 19.6% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 31 | 80 | $9,840 | $4,991 | 50.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 35 | 36 | $44,280 | $4,333 | 9.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 33 | 49 | $5,635 | $2,204 | 39.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 28 | $10,360 | $1,882 | 18.2% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 16 | 18 | $3,132 | $1,588 | 50.7% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 30 | 40 | $3,000 | $1,142 | 38.1% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 15 | 22 | $1,760 | $872.30 | 49.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 12 | 15 | $2,100 | $783.16 | 37.3% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 14 | 14 | $1,610 | $629.58 | 39.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 24 | 24 | $28,458 | $2,923 | 10.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 16 | 16 | $12,352 | $1,163 | 9.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 15 | 19 | $10,001 | $904.46 | 9.0% |
About Jamie Interlichia, PA-C
Jamie Interlichia, PA-C is a Medical healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1124278841.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jamie Interlichia, PA-C has received a total of $3,726 in payments from pharmaceutical and medical device companies, with $1,037 received in 2024. These payments were reported across 33 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,726).
As a Medicare-enrolled provider, Interlichia has provided services to 796 Medicare beneficiaries, totaling 1,255 services with total Medicare billing of $72,002. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Location Buffalo, NY
- Active Since 09/30/2008
- Last Updated 01/13/2026
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1124278841
Products in Payments
- INGREZZA (Drug) $249.94
- LOKELMA (Drug) $245.80
- OPDIVO (Biological) $234.43
- Descovy (Drug) $224.99
- Austedo XR (Drug) $200.85
- Kerendia (Drug) $197.82
- Xolair (Biological) $148.09
- Xofluza (Drug) $140.40
- APTIMA (Device) $132.84
- Hizentra (Biological) $124.99
- NUPLAZID (Drug) $124.99
- Prolastin-C Liquid (Biological) $124.99
- Wegovy (Drug) $124.99
- VRAYLAR (Drug) $121.83
- FREESTYLE LIBRE 2 (Device) $121.82
- NURTEC ODT (Drug) $120.35
- XIFAXAN (Drug) $119.83
- IFUSE IMPLANT (Device) $119.28
- QUVIVIQ (Drug) $114.51
- FARXIGA (Drug) $114.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Buffalo
Ms. Lauren Wiatrowski
Medical — Payments: $14,998
Medical $14,998
Patrick George, Pa, PA
Medical — Payments: $5,591
Medical $5,591
Miss. Michaela Hoeflich, Pa, PA
Medical — Payments: $5,473
Medical $5,473
Mr. Daniel Fells, Rpa-C, RPA-C
Medical — Payments: $5,268
Medical $5,268
Mrs. Dessialis Cruz, Rpa-C, Mpa, RPA-C, MPA
Medical — Payments: $4,910
Medical $4,910
James Mikulsky, Rpa C, RPA C
Medical — Payments: $4,876
Medical $4,876